All News about Mirum Pharmaceuticals, Inc. - common stockVia Benzinga
Mirum Pharmaceuticals Added to NASDAQ Biotechnology Index
December 15, 2021
Via Business Wire
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
November 22, 2021
Via Business Wire
Via Business Wire
FDA Approves First Treatment For Alagille Syndrome-Associated Cholestatic Pruritus From Mirum Pharma
September 29, 2021
Via Benzinga
Exposures
Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|